The Kaufman Lectureship
in the Gastroenterology Division
In March 2002, Dr. David Kaufman passed away unexpectedly. At the time of his death, David was the secretary general of the Henry L. Bockus International Society of Gastroenterology and former president of the medical staff and chief of Internal Medicine at Trinitas Hospital in Elizabeth, New Jersey. David was also a recognized authority for inflammatory bowel disease in the northern New Jersey region.
Through the efforts of family, friends, and members of David Kaufman’s undergraduate class of 1952 and medical school class of 1956 at the University of Pennsylvania, the David Kaufman Memorial Funds were established at the School of Medicine. The endowed funds will support two important projects at the School: The Kaufman Lectureship in the Gastroenterology Division, and the Kaufman Global Health Initiative Travel Fund, in support of a groundbreaking program that sends medical students to under served communities around the globe.
To learn more about GI Lectureships or to make a gift to the Kaufman Global Health Initiative Travel fund in memory of David Kaufman, please contact Evelyn Schwartz, Director of Development, Abramson Cancer Center, 215-898-8625, email@example.com.
The following is a list of the speakers of the Kaufman Lectureship:
Ruslan Medzhitov, PhD
Howard Hughes Medical Institute, Immunology Section
Yale University School of Medicine
"Immunolobiology of host-microbial interactions"
Elizabeth M. Jaffee, MD
Co-Director, Division of Immunology
Professor of Oncology, Immunology, and Cell and Molecular Medicine
The Dana and Albert Broccoli Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
“Genes, vaccines, and immune checkpoints: raising hope for pancreatic cancer therapy”
Stanley M. Lemon, MD
John Sealy Distinguished University Chair
Professor, Departments of Microbiology & Immunology and Internal Medicine
Director, Institute for Human Infections and Immunity
The University of Texas Medical Branch at Galveston
"Hepatitis viruses and innate host defenses"
Mary K. Estes, PhD
Cullen Endowed Chair of Molecular and Human Virology
Departments of Molecular Virology and Microbiology & Medicine
Baylor College of Medicine
"Norovirus gastroenteritis: pathogenesis, host susceptibility and vaccines"
Raphael Kopan, PhD
Professor, Department of Developmental Biology
Department of Medicine, Division of Dermatology
"Notch signaling in adult lineages: new tools lead to new insights"
Frédéric Lemaigre, MD, PhD
Professor of Molecular Biology
Université catholique de Louvain de Duve Institute
"Transcription factor-microRNA networks in liver and pancreatic cell differentiation"
Gloria M. Petersen, PhD
Professor of Epidemiology
Mayo Clinic College of Medicine
" Recent advances in the molecular epidemiology of pancreatic cancer"
Yibin Kang, PhD
Warner-Lambert/Parke-Davis Professor of Molecular Biology
"Epithelial to mesenchymal transtions in cancer metastasis"
The Charlotte and Irving Shapiro Lecture
The son of Lithuanian immigrants, Irving Shapiro (1916-2001) graduated from the University of Minnesota Law School in 1941 and held a variety of government positions during and after World War II. In 1948, as a lawyer for the Justice Department, he won his first case before the Supreme Court. Three years later he joined DuPont's legal team. Mr. Shapiro grew intimately acquainted with the company during the lengthy General Motors-DuPont antitrust suit, and as the chief architect of the settlement won the trust of the du Pont family. Shapiro became assistant general counsel in 1965 and five years later was appointed to the Executive Committee. In July 1973 he became vice chairman, preparing the way for his succession to becoming Chairman and CEO in December 1973. Mr. Shapiro steered DuPont successfully through many issues in the 1970s. Under Mr. Shapiro's stewardship, DuPont expanded its overseas operations. Mr. Shapiro retired in 1981 but continued to practice law in Wilmington and provide counsel to DuPont into the 1990s.
Irving Shapiro, and his wife, Charlotte Shapiro, established in 1998 an annual lecture to highlight distinguished researchers within the Division of Gastroenterology at the University of Pennsylvania.
The following is a list of the speakers of the Shapiro Lectureship:
Anil K. Rustgi, MD
University of Pennsylvania
Ken Kinzler, PhD
Johns Hopkins University
George Michaelopoulos, MD, PhD
University of Pittsburgh
Montgomery Bissell, MD
University of California at San Francisco
Stefan Targan, MD
Cedars Sinai Hospital, UCLA
"Mucosal specific mechanisms of IFN-g regulation"
Fiona Powrie, PhD
University of Oxford
"Control of immune pathology by regulatory T cells"
Hans Clevers, PhD
Linheng Li, PhD
Stowers Institute for Medical Research
"Stem cell regulation in intestinal and hematopoietic systems"
Matthew Meyerson, MD, PhD
Harvard Medical School
"Genomic studies of human cancer"
Brigid L.M. Hogan, PhD, FRS
"Lung stem cells in development and repair"
Mina J. Bissell, PhD
Lawrence Berkeley National Laboratory
"The importance of tumor microenvironment in initiation, promotion, and therapy of cancer"
Michael Karin, PhD
Tumor Growth, Invasion & Metastasis Program
University of California, San Diego
"Inflammation, metabolism, aging and cancer: dangerous liaisons"
Eric Fearon, M.D.. PhD
Chief, Molecular Medicine & Genetics
Emanuel N. Maisel Professor of Oncology
Professor of Internal Medicine, Human Genetics & Pathology
Associate Director for Basic Science
University of Michigan, Comprehensive Cancer Center
"The use of mouse models to explore the molecular pathogenesis of colorectal cancer"
Carol Prives, PhD
Da Costa Professor of Biology
Department of Biological Sciences
"Lessons learned from studying the p53 tumor suppressor protein"
Andrea Califano, PhD
Professor of Systems Biology
Chief, Division of Biomedical Informatics
Director, Columbia Initiative in Systems Biology
Director, Center for the Multiscale Analysis of Genomic Networks
Associate Director for Bioinformatics, Herbert Irving Comprehensive Cancer Center
"Analysis of gene regulatory networks elucidates master regulators of tumor initiation, progression, and chemosensitivity"